Radius VSM ECG pre-connected Set, REF: 4842, 4695
FDA Device Recall #Z-2670-2026 - Class II, February 20, 2026
Recall Summary
| Recall Number | Z-2670-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | February 20, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Masimo Corporation |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 772 |
Product Description
Radius VSM ECG pre-connected Set, REF: 4842, 4695
Reason for Recall
Two devices recalled: 1) Electrocardiogram (ECG) electrode assembly ECG feature may incorrectly detect extreme bradycardia, tachycardia and trigger alarms on normal heart rate patients, which may distract clinicians away from management of true positive alarms, which could delay treatment; 2) Small and medium size blood pressure cuffs may contain rough edges, may result in skin irritation/redness.
Distribution Pattern
Worldwide - US Nationwide distribution in the states of OK, CA , MD , MA , NY , UT , NC , TN , MN , TX , OH , PA , VA and the countries of Italy, Latvia, Iraq, Saudi Arabia, Germany, Spain, Turkey, France, Australia, Malta, Oman, United Arab Emirates, Martinique, Netherlands, Cyprus, Kuwait, Czech Republic, United Kingdom, Croatia, Switzerland, Belgium, Singapore, Romania, Colombia, Hong Kong, Israel, Finland, Poland, New Zealand, Tunisia, Chile, Algeria, Canada, Denmark, Palestinian Territory, Qatar, Greece, Paraguay.
Lot / Code Information
REF/UDI-DI/Lot: 4842/10843997011003/25AJH, 25KMA, 25MSC 4695/10843997016015/24N17, 25BBJ, 25DMH, 25FBR, 24KLV, 24N17, 25AGZ, 25BBJ, 25D10, 25DMH, 25FBR, 25GJM, 25KBF
Other Recalls from Masimo Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2671-2026 | Class II | Radius VSM Disposable NIBP Cuff, REF: 4825, 4826 | Feb 20, 2026 |
| Z-1538-2024 | Class II | Masimo Rad-G, Pulse Oximeter (W/Patient Cable),... | Feb 15, 2024 |
| Z-1537-2024 | Class II | Masimo Rad-G, Pulse Oximeter (W/Sensor), REF:98... | Feb 15, 2024 |
| Z-1536-2024 | Class II | Masimo Rad-G, Pulse Oximeter with temperature (... | Feb 15, 2024 |
| Z-1539-2024 | Class II | Masimo Rad-G, Pulse Oximeter (W/Patient Cable),... | Feb 15, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.